House of Lords Business
Show full summary

Baroness Ritchie of Downpatrick to ask His Majesty's Government whether they have commissioned research to understand where rapid diagnostics should be used in care pathways to ensure influenza Neuraminidase Inhibitor (NI) drugs and COVID-19 therapies are prescribed as soon as possible after infection, in order to reduce winter admissions. 

Question HL3911: tabled on 30 November 2022 and due for answer by 14 December 2022

This type of business sits within the Questions & Statements category.

This question has been answered by the relevant Government Department.

Question text

Baroness Ritchie of Downpatrick to ask His Majesty's Government whether they have commissioned research to understand where rapid diagnostics should be used in care pathways to ensure influenza Neuraminidase Inhibitor (NI) drugs and COVID-19 therapies are prescribed as soon as possible after infection, in order to reduce winter admissions.  HL3911
Legend for business item text
† Item that is new or altered.
* Item is an oral question.
Numbers starting HL are unique identifiers for written questions, Bills or papers.

Date Answered

Friday 9 December 2022

Member's Registered Interests

There are no interests to show.

Main Member

Baroness Ritchie of Downpatrick
Labour
Life peer